Expect TRIM17, TRIM46, TRIM50, TRIM62, TRIM65, and TRIM7, the other 10 TRIMs, were found to upregulate in HBV-positive HCC in the GSE55092 cohort (p < 0.05). Here, TRIM17 is linked to hepatocellular carcinoma.